Low-Dose Naltrexone for Complex Regional Pain Syndrome
Low-Dose Naltrexone for the Treatment of Complex Regional Pain Syndrome
- Age
- 18 – 70
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 120 (estimated)
- Sponsor
- Stanford University · Other
This trial is looking for adults with Complex Regional Pain Syndrome (CRPS) who have had the condition for at least a year. Participants will receive either low-dose naltrexone or a placebo for several weeks and will attend study visits and fill out questionnaires.
You may be able to join if
- I have Complex Regional Pain Syndrome in my arms or legs.
- I have had CRPS for at least 1 year.
- I have been on stable treatment for my condition for 1 month.
- I meet the Budapest criteria for CRPS.
You may not be able to join if
- I am allergic to naltrexone or naloxone.
- I use prescription opioid pain relievers or illegal opioids.
- I am currently pregnant or planning to become pregnant.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityThe investigators are testing treatment with low-dose naltrexone (LDN) for symptom relief of complex regional pain syndrome (CRPS). Study participants will be randomly assigned to receive either LDN or placebo for a period of several weeks. During this period participants will be asked to attend either in-person or virtual study visits and complete questionnaires.
Loading trial locations…